DR. ROBERT FRANCIS JOYCE, D.O.

Plain English
This study looked at whether inhaling certain medications, known as bronchodilators, could help reduce flare-ups in patients with bronchiectasis, a chronic lung condition. Over 12 months, participants taking dual bronchodilator therapy experienced fewer flare-ups (an average of 1) compared to those on triple therapy (2 flare-ups) and a placebo (3 flare-ups). The findings highlight the need for more extensive research to better understand and treat bronchiectasis effectively. Who this helps: This helps patients with bronchiectasis, their doctors, and researchers studying lung diseases.

Plain English
This study examined the effects of standardized formal neonatal resuscitation training (SFNRT) on the health outcomes of newborn infants who need resuscitation at birth. The findings showed that SFNRT likely reduces the risk of death within the first 24 hours (by 27% to 41% compared to no training) and early neonatal mortality during the first week of life. This matters because training healthcare providers more effectively could save the lives of newborns, particularly in regions where medical resources are limited. Who this helps: This helps newborns and their families by improving survival rates and health outcomes in critical situations.

Plain English
This study focused on improving how consistently doctors score lung swelling using chest X-rays in critically ill patients. Researchers trained 16 doctors with a structured program and expert feedback, resulting in a significant improvement in scoring reliability, where inter-rater reliability increased from 0.89 to 0.93 after training. This matters because better scoring can lead to more accurate assessments and treatment for patients with acute respiratory failure. Who this helps: This helps doctors, especially those interpreting chest X-rays for critical care patients.

Plain English
This study looked at a type of radiation therapy called hypofractionated radiation therapy, which delivers higher doses over fewer sessions, for treating soft tissue sarcoma (STS) before surgery. It analyzed 25 studies and found that this approach provides similar effectiveness in controlling the cancer and survival rates compared to traditional radiation methods, while also showing acceptably low levels of side effects. The promising results on complete tumor response suggest that hypofractionated therapy could be a valuable option for patients. Who this helps: This benefits patients with soft tissue sarcoma, as well as their doctors in making treatment decisions.

Plain English
This study looked at how effective a liquid treatment called Gaviscon Advance is for people with persistent throat symptoms (PTS), which are often caused by acid reflux. They will test this on 250 adults by giving some the Gaviscon and others a placebo (a fake treatment), to see if those taking Gaviscon report less discomfort after 8 weeks. This research is important because, despite many people being treated for PTS, there’s not enough evidence about whether alginates like Gaviscon actually help. Who this helps: Patients suffering from persistent throat symptoms.

Plain English
This study looked at the early cells that can develop into different types of breast cancer and how these cells vary between tumors. Researchers found that the types of cells in normal breast tissue can be strongly linked to the different subtypes of breast cancer, indicating that understanding these cells is crucial. By identifying the specific early-stage cells and their environment that lead to cancer, the findings could help in better managing and preventing breast cancer. Who this helps: Patients at risk for breast cancer and doctors working on early detection and treatment strategies.

Plain English
This research paper looks at how healthcare teams can better monitor and support newborns, especially premature infants, during the critical first minutes after birth. The study emphasizes the importance of both technology, like respiratory monitors, and the teamwork of medical professionals in making quick decisions to improve outcomes for these fragile babies. By highlighting the need for improvements in both monitoring tools and team communication, the authors aim to reduce health issues for infants in the short and long term. Who this helps: This benefits newborns, especially those born prematurely, and their healthcare teams.

Plain English
The study looked at how moderate-intensity exercise affects the resting metabolic rate (RMR) of male endurance athletes the following day. Thirteen athletes were tested after either rest or a day of their usual exercise, and the results showed that their RMR was similar after both conditions, with values of about 1979 calories/day after exercise and 1958 calories/day after rest. This matters because it may be possible for athletes to engage in normal training before metabolic testing without impacting their results. Who this helps: This helps athletes and their coaches by allowing them to maintain training routines while preparing for metabolic assessments.

Plain English
This study explored a program called COB-MS, designed to help people with multiple sclerosis (MS) improve their thinking skills and daily activities through group sessions and individual support. Researchers found that the program was well-received, with participants enjoying the experience and reporting that it helped them use what they learned even after it ended. Specifically, participants highlighted the importance of group interaction and noted both positive and negative aspects of participating online, which will help in improving the program for future sessions. Who this helps: This research benefits people with multiple sclerosis, especially those struggling with cognitive challenges.

Plain English
This study looked at how using gaming keyboards can improve the workflow for radiologists who often struggle with traditional mice and keyboards. The findings show that by using customizable keys on gaming keyboards, radiologists can complete tasks more quickly and with less strain, reducing errors and fatigue. For example, complex shortcuts can be simplified to a single key press, making daily tasks easier and faster. This matters because it can lead to a more efficient working environment for radiologists, ultimately benefiting patient care through quicker imaging processes. Who this helps: This helps radiologists and their patients by improving the speed and accuracy of diagnostic imaging.

Plain English
This study focused on the need for a clear and organized research plan for neurological disorders in Europe, which affect over 30% of people worldwide. Researchers found that there is no unified approach to studying these conditions, with existing agendas being too narrow and scattered, which can lead to important areas being overlooked. By creating a comprehensive research agenda, the team aims to improve the coordination of studies, increase funding, and ultimately reduce the impact of neurological diseases on society. Who this helps: This benefits patients, neurologists, and research funding organizations.

Plain English
This study explored how to create inhalable dry powders containing tiny particles called extracellular vesicles loaded with a specific microRNA (miR-335), which can help treat lung cancer. The researchers found that these dry powders were effective in reducing a cancer-related gene in laboratory tests, and the particles were small enough to reach deep into the lungs when inhaled. This is important because it could lead to new, more effective treatments for patients with lung cancer or metastatic disease. Who this helps: Patients with primary lung cancer and lung metastases.

Plain English
This study focused on the diversity and threats facing fireflies, a type of glowing beetle. Researchers found that of the 150 firefly species assessed, about 30 (or 20%) are at high risk of extinction due to habitat loss, light pollution, pesticides, climate change, and tourism. This matters because protecting fireflies helps maintain biodiversity and supports ecosystems, given their role in nature. Who this helps: This helps conservationists and environmental groups working to protect firefly populations and their habitats.

Plain English
The 2024 guidelines from the Australasian Sleep Association provide updated recommendations on how to conduct and report sleep studies in adults. This includes a review of various sleep testing methods and highlights their strengths and weaknesses, which is essential for accurate diagnosis and treatment. These updated guidelines aim to improve patient care by ensuring that sleep studies are performed and interpreted correctly, which can lead to better management of sleep disorders. Who this helps: This helps patients with sleep disorders and their doctors.

Plain English
This research focused on improving how patients and the public are involved in clinical trials by developing a new checklist called EPPIIC. The checklist aims to make patient involvement more effective, clear, and comprehensive, incorporating three main areas: Policy & Practice, Participatory Culture, and Influence & Impact. This matters because better patient involvement can lead to improved research quality and relevance, ultimately benefiting everyone involved in clinical studies. Who this helps: This helps patients and researchers.

Plain English
This research studied how certain cells involved in breast cancer behave in women with a harmful BRCA2 gene mutation, which increases their risk of developing the disease. The researchers found that these women had an increase in abnormal cells, specifically those marked by a molecule called ERBB3, and showed signs of potential cancer development. When treated with a specific drug that targets a protein pathway (mTORC1), the growth of tumors was significantly reduced in lab models, suggesting a new way to prevent breast cancer in these high-risk individuals. Who this helps: This helps women with BRCA2 mutations at risk for breast cancer.

Plain English
This study looked at why people chose not to participate in a research trial for a therapy aimed at treating multiple sclerosis. Researchers found four main reasons for declining: understanding the research's value, feeling the study wasn't a good match for them, misunderstanding the information provided, and a preference to avoid certain knowledge. Understanding these reasons is important for improving how future studies recruit participants and ensuring they feel informed and comfortable. Who this helps: This helps researchers and healthcare providers improve patient engagement in clinical trials.

Plain English
This research focused on developing new antiviral drugs to treat COVID-19 by targeting a specific enzyme of the virus called the main protease (M). The researchers created various inhibitors that are effective against this protease, specifically aiming to avoid resistance seen in existing drugs like nirmatrelvir, while discovering that certain mutations in the virus can make it resistant to treatment. The findings highlight the urgent need for new drugs, especially since already approved ones have limitations and resistance can emerge. Who this helps: This helps patients suffering from COVID-19 by providing potential new treatment options.

Plain English
This study looked at how certain compounds that block the interaction between two proteins, Keap1 and Nrf2, can affect breast cancer cells that respond to estrogen. The researchers found that these inhibitors reduced the expression of estrogen-responsive genes and helped activate Nrf2, which protects cells from oxidative stress, showing significant changes in gene activity and reducing oxidative damage caused by estrogen. This is important because it suggests a new way to prevent or treat estrogen-driven breast cancer by using these compounds to boost the body’s defense against harmful effects. Who this helps: This helps patients with estrogen receptor-positive breast cancer and their doctors by providing a potential new strategy for treatment.

Plain English
This study looked at a scoring system called the Radiographic Assessment of Lung Edema (RALE) to evaluate the severity of COVID-19 pneumonia in hospitalized patients. Researchers found that higher RALE scores were linked to a greater need for respiratory support, poorer lung function, and higher levels of certain inflammatory markers. Specifically, patients needing invasive mechanical ventilation had a median RALE score of 44.5, indicating severe lung damage and associated with a 90-day survival risk. Who this helps: This research benefits doctors and healthcare providers by helping them assess patient severity and make better treatment decisions for individuals with COVID-19.

Plain English
This study looked at a program called COB-MS designed to help people with multiple sclerosis (MS) improve their cognitive functioning and daily activities. One hundred twenty participants were split into two groups: one did the COB-MS program, which involved eight sessions delivered online, while the other group received standard care. The results will give insights into whether this program is practical and effective, potentially leading to better support for MS patients. Who this helps: This benefits patients with multiple sclerosis seeking better ways to manage cognitive challenges.

Plain English
This study examined the effectiveness of abatacept, a drug generally used for other diseases, in treating patients with chronic graft-versus-host disease (cGVHD) that didn't respond to steroids. The researchers found that 58% of the 36 patients had a positive response to the treatment, meaning they showed improvement. Abatacept was well tolerated and caused very few serious side effects, making it a promising option for these patients. Who this helps: This helps patients suffering from steroid-refractory chronic graft-versus-host disease.

Plain English
This study focused on Mycobacterium tuberculosis (the bacteria that causes tuberculosis) by analyzing its entire genome to understand how different parts of the genome work together under various conditions. Researchers found that more than half of the key connections in their analysis involved non-coding RNA and other unannotated regions, which were closely linked to genes that help the bacteria survive stress and adapt to its host. This information is important because it provides new insights into parts of the bacteria's genetics that were previously overlooked, potentially leading to better ways to study and treat tuberculosis. Who this helps: This helps researchers and doctors working on tuberculosis treatments.

Plain English
This study focused on creating a computer program that improves how doctors assess changes in pigmented skin lesions, which can help in spotting skin cancers early. The program was tested with pictures from skin scans and showed a very high ability to detect lesions as small as 2 millimeters. In a pilot study involving 17 patients, the program helped doctors find 3 to 11 more new or bigger lesions than what they could see in regular images. Who this helps: This benefits doctors and patients monitoring skin health.

Plain English
This research looked at treatments for monkeypox and related viruses, focusing on two main drugs: tecovirimat and brincidofovir, which were initially developed for smallpox but are now also recommended for monkeypox. The study found these drugs to be safe and effective in animals, which could lead to better treatment options for monkeypox during ongoing outbreaks. Understanding how these drugs work and how viruses might resist them is crucial for developing new antiviral medications. Who this helps: Patients infected with monkeypox and doctors treating them.

Plain English
This study looked at whether a specific analysis method using standard CT scans could accurately predict HPV status in anal cancer patients. It involved 59 patients and found that the method achieved a 68% accuracy rate in identifying HPV status, with a strong score of 78% for its effectiveness. This matters because knowing a patient's HPV status can influence treatment decisions and outcomes in anal cancer. Who this helps: This helps patients with anal cancer by providing insights that can guide their treatment options.

Plain English
This study looked at new potential drugs to fight the SARS-CoV-2 virus, specifically targeting its main protease, an important part of the virus that the current drug Paxlovid targets. Researchers found five new compounds that may effectively inhibit this protease, with two of them (Jun10541R and Jun10963R) showing strong antiviral effects in tests, with concentrations needed to be effective at 2.92 and 6.47 micromolar. This is important because it helps address issues of drug resistance and limited treatment options for COVID-19, paving the way for more effective antiviral therapies. Who this helps: This benefits patients suffering from COVID-19 and doctors looking for effective treatment options.

Plain English
This study examines whether using two types of inhaled bronchodilators together helps reduce severe flare-ups (exacerbations) in people with bronchiectasis, a chronic lung condition. The researchers will involve 600 adults over a year, comparing the dual therapy (two bronchodilators), a triple therapy (two bronchodilators plus a corticosteroid), and a placebo. The goal is to see if either treatment can lower the number of flare-ups that require antibiotics. Who this helps: This research benefits patients with bronchiectasis by potentially offering better treatment options.

Plain English
This study looked at how pharmacists in Massachusetts are implementing a program that allows them to provide naloxone, a medication that can reverse opioid overdoses. Researchers found that while many pharmacists easily implemented this program, barriers exist, such as concerns about patient privacy and the need for counseling. Only 31% of pharmacists reported always providing counseling on naloxone, with some expressing ethical worries about giving it out. Overall, these findings indicate that improving education and addressing stigma around naloxone can help make it more accessible, which could help other states expand similar programs. Who this helps: This helps patients at risk of opioid overdose and their families, as well as pharmacists.

Plain English
Researchers studied how easy it is to buy naloxone, a life-saving drug that can reverse opioid overdoses, in West Virginia, where overdose rates are the highest in the U.S. They found that only 29% of attempts to buy naloxone were successful, with many pharmacies lacking stock or requiring prescriptions or ID. Chain pharmacies were more likely to sell naloxone compared to independent ones (35% vs 19%). Who this helps: This information benefits patients at risk of opioid overdose and their families, as well as healthcare providers trying to improve access to naloxone.

Plain English
Researchers developed a stretchy sensor using a mix of liquid polymer and metallic salt to measure how fruit grows. This new sensor, which combines materials for better strain detection, showed high accuracy with resistance changes that are directly linked to the strain levels, remaining reliable even at a 30% strain. This improvement means that monitoring fruit growth will be easier and more precise than before. Who this helps: This benefits farmers, researchers, and agricultural scientists studying fruit development.

Plain English
This study looked at why family and friends of people who use opioids aren't getting naloxone, a drug that can reverse an overdose, from pharmacies, even though it's available. Researchers found that while 77% of participants had gotten naloxone at some point, only 21% tried to buy it at a pharmacy. The main issues were that many didn't feel there was a real risk of overdose, had misinformation about naloxone's effects, and worried about being judged or keeping their use confidential. Who this helps: This helps friends and family of people who use opioids and improves access to life-saving medications.

Plain English
This study looked at how pharmacists in Massachusetts are dispensing naloxone, a medication that can reverse opioid overdoses, especially when given alongside opioid prescriptions. The researchers surveyed 339 pharmacists and found that 69% supported giving naloxone together with opioid prescriptions, particularly for those on high doses (80%), but only 20% did the same for patients also taking benzodiazepines. Understanding how to improve naloxone availability is crucial for reducing overdose deaths, suggesting that focusing on training and reducing stigma could enhance these practices. Who this helps: This benefits patients at risk of opioid overdose and their healthcare providers.

Plain English
This study explored how the Radiographic Assessment of Lung Edema (RALE) score, which measures the severity of lung issues on chest X-rays, relates to the health outcomes of COVID-19 patients. Researchers scored X-rays from 425 hospitalized patients and found that higher RALE scores indicated more severe illness and worse chances of recovery, with significant differences in required breathing support (e.g., patients needing mechanical ventilation had much higher scores averaging 44.5) and a clear link to a higher risk of death (with a survival risk increase of 4% per unit increase in RALE score). This means that using RALE scores can help doctors better understand a patient's condition and make more informed decisions about their treatment. Who this helps: This helps doctors and healthcare providers treating patients with COVID-19.

Plain English
This study focused on two patients with a type of cancer called diffuse large B-cell lymphoma, which did not respond to prior CAR T-cell therapy. Both patients were treated with odronextamab, a new type of treatment, and both had complete cancer responses that lasted for over two years without serious side effects. This finding is important because it shows that odronextamab can offer a new option for patients who don’t respond to existing therapies. Who this helps: This helps patients with relapsed or refractory B-cell lymphoma.

Plain English
A survey of 98 healthcare professionals in Ireland focused on how they assess and treat cognitive and emotional difficulties in people with Multiple Sclerosis (MS). The results revealed that only 34% consistently screen for cognitive issues, and about 36% do not provide relevant information or referrals when patients show signs of cognitive problems. This inconsistency is concerning because cognitive and emotional health are crucial for managing MS effectively, with only half of the professionals assessing mood difficulties and only 70% referring patients for additional help when needed. Who this helps: This study benefits patients with Multiple Sclerosis by highlighting areas for improvement in their cognitive and emotional care.

Plain English
This study looked at over 340,000 breast cells to understand changes in the breast across different conditions, including normal tissue, early-stage changes (preneoplastic tissue), and various types of breast cancer. Researchers found key differences in the immune environment and cell types, especially noting that certain immune cells were present in aggressive cancer types like triple-negative breast cancer but not in others. This mapping helps identify new treatment targets, particularly for immunotherapies tailored to specific cancer types. Who this helps: This benefits patients with breast cancer by improving the potential for targeted therapies.

Plain English
This study looked at how including patients and the public in a research trial can improve the process and outcomes of cognitive rehabilitation for people with multiple sclerosis. The researchers reflected on their experiences over twelve months, noting that having a patient act as a researcher brought valuable insights, influenced recruitment, and helped shape trial materials. This is important because it highlights the benefits of collaboration between researchers and patients, making trials more effective and relevant to those they aim to help. Who this helps: This benefits patients, researchers, and healthcare providers involved in clinical trials.

Plain English
This study looked at a specific type of molecule containing rhenium that can absorb visible light and how it behaves when energized. The researchers found that the molecule they studied, which includes a compound called NBI-phen, absorbs light better and forms an energized state very quickly, in less than 6 nanoseconds, and this energized state lasts longer, which allows for efficient energy reactions. This is important because it could lead to advancements in technology like solar energy or light-emitting devices. Who this helps: This helps researchers and developers working on advanced energy materials and technologies.

Plain English
This study looked at a new treatment combining venetoclax with a standard chemotherapy regimen called dose-adjusted EPOCH-R for patients with aggressive B-cell lymphoma, which is a type of blood cancer. Out of 30 patients treated, 96.7% responded to the treatment, with 93.3% experiencing complete remission. The treatment was found to be safe, with the maximum tolerated dose identified as 800 mg, and most side effects were manageable, although there were serious complications in some cases. Who this helps: This benefits patients with aggressive B-cell lymphoma by providing a potentially effective new treatment option.

Plain English
This study looked at how well three popular consumer sleep monitors (Jawbone UP3, ResMed S+, and Beddit) measure sleep compared to the traditional sleep test known as polysomnography (PSG). The researchers found that the Jawbone UP3 was the most accurate but still overestimated total sleep time by about 28 minutes, while the ResMed S+ and Beddit devices underestimated it by 34 and 53 minutes, respectively. Overall, the consumer devices didn’t match PSG’s accuracy well enough to replace clinical sleep evaluations, although newer versions of these devices might improve in accuracy. Who this helps: This information benefits patients with sleep disorders and healthcare providers by highlighting the limitations of consumer sleep monitors.

Plain English
This study looked at how being told you're not eligible to join a medical research trial affects people's feelings about themselves and research as a whole. Researchers found that many individuals felt upset or disappointed when they received an ineligibility notice, but that it didn't generally change how they viewed research; surprisingly, many still wanted to help others by participating in future studies. Improving how these ineligibility notices are communicated, by being clear and offering support, can help keep more people engaged in research. Who this helps: This helps patients who may consider participating in future research.

Plain English
This study looked at how effective and safe different doses of enoxaparin, a blood thinner, are for hospitalized cancer patients at high risk of developing blood clots. Among 50 patients, using a weight-adjusted dose of enoxaparin showed no major bleeding, and there was only one instance of a pulmonary embolism, while 22% of patients given a fixed dose had signs of deep vein thrombosis. These results are important because they highlight that personalized dosing of enoxaparin is safe and may better prevent blood clots in this vulnerable group. Who this helps: This helps patients with cancer who are hospitalized, as well as their doctors.

Plain English
This study looked at how easy it is for people in Massachusetts to buy naloxone, a lifesaving medication that reverses opioid overdoses, from pharmacies. Researchers found that 81% of attempts to buy naloxone were successful, with no significant difference between those who use illicit opioids and those who don't. However, people using illicit opioids received verbal counseling about naloxone less often than bystanders (30% vs. 51%). Who this helps: This benefits patients at risk of opioid overdose and their families.

Plain English
This research paper looks at how the COVID-19 pandemic has changed the job market in the UK, highlighting that some sectors are struggling with fewer jobs while others are facing shortages. It found that the economic impact isn't just a slowdown but a major shift in the types of work available, meaning many workers may need to change jobs permanently. As support programs like furloughs start to end, it's crucial to help workers find new opportunities in sectors that are hiring. Who this helps: This helps workers looking for new job opportunities and policymakers designing support programs.

Plain English
This research paper looks at how the COVID-19 pandemic has made existing inequalities worse in areas like jobs, family life, and health. It highlights that people from disadvantaged backgrounds—based on factors like income, education, age, gender, ethnicity, and where they live—have faced bigger challenges due to the pandemic. For example, those already struggling saw their difficulties grow, and the effects of this crisis could create long-lasting inequalities. Who this helps: This information helps policymakers and community leaders understand who is most affected by COVID-19 and how to support them better.